Incyte Corporation
126.01USD
+1.6100 (+1.29%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,273 | 1,507 | 1,366 | 1,216 | 1,053 | 1,179 | 1,138 | 1,044 |
| Cost of Revenue | 105 | 121 | 99 | 79 | 73 | 88 | 86 | 77 |
| Gross Profit | 1,168 | 1,386 | 1,267 | 1,137 | 980 | 1,090 | 1,052 | 967 |
| Operating Income | 301 | 336 | 444 | 530 | 205 | 302 | 146 | -478 |
| Net Income | 303 | 299 | 424 | 405 | 158 | 201 | 106 | -445 |
| EPS (Diluted) | $1.47 | $1.46 | $2.11 | $2.04 | $0.80 | $0.95 | $0.54 | $-2.04 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)